secwatch / observer
8-K filed September 19, 2025, 7:59 PM ET ticker DRIO CIK 0001533998
other material confidence high sentiment neutral materiality 0.60

DarioHealth accelerates mandatory conversion of Series C & D preferred stock into common stock

DarioHealth Corp.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

DarioHealth Corp.: Amended and restated certificates of designation for Series A-1, Series C, C-2, D, D-1, D-2, and D-3 preferred stock to accelerate mandatory conversion period and provide option for pre-funded warrants (effective 2025-09-18).

Change
charter amendment
Effective
2025-09-18
Exact text from the filing
On September 18, 2025, DarioHealth Corp. (the “Company”), upon obtaining the vote of a majority of the holders of the relevant classes of preferred stock and the approval of the Company’s Board of Directors, filed an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company’s Series A-1 Preferred Stock (the “Series A-1 Certificate of Designation”), an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company’s Series C Preferred Stock (the “Series C Certificate of Designation”), an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company’s Series C-2 Preferred Stock (the “Series C-2 Certificate of Designation”, collectively with the Series C Certificate of Designation, the “Series C Certificates of Designation”), an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company’s Series D Preferred Stock (the “Series
View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

DarioHealth Corp. filing history →

Source: SEC EDGAR
accession 0001104659-25-091718
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.